Aehr Test Systems

NASDAQ:AEHR

Semiconductors

Technology
$49.74 +4.72%

+$5.32 today

Market cap
$1.63B
Beta
3.18
P/E (TTM)
-317.1
EPS (TTM)
-$0.37
52W Low $10.89High $126.62

Volume 2.27M

Average 2.97M

AEHR Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Aehr Test SystemsNASDAQ: AEHR

Research & Development · Q4 FY2026 · quarter ended May 2026

Research & development growth accelerates

Q4 FY2026 research & development of $3.65M rose 35.7% year over year, ahead of the +20.7% change in trailing-twelve-month research & development. Sequentially, it rose 15.1% from the prior quarter. Over 3 fiscal years it compounded at +21.0% a year.

Context

  • Research & development amounted to 25.3% of revenue in FY2026, up 7.5 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +35.7% holds above the trailing-twelve-month pace of +20.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMay 2026
$3.65M+15.1% QoQ
Last fiscal yearMay 2026
$12.63M+20.7% YoY
LTMMay 2026
$12.63M+20.7% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+35.7%——
1 year+20.7%——
3-year CAGR+21.0%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
12.63M USD
Year-over-year change
+20.7%
4-year CAGR
+21.4%

Research & Development vs competitors

How AEHR compares with its peers on the latest reported figures

  • AEHR's LTM May 2026 research & development of $12.63M is the 4th highest of the 5 companies compared; the peer median is $109.49M.
  • Its year-over-year change of +20.7% is the highest of 5, against a peer median of +8.2%.
  • Research & development amounts to 24.8% of revenue for AEHR, versus a peer median of 12.5%.
AEHR Competitors Peer median
Research & Development for AEHR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TERTeradyne, Inc.LTM Jun 2026$559.87M +16.1%+4.6%12.5%
FORMFormFactor, Inc.LTM Sep 2026$121.79M +5.2%+2.0%12.4%
COHUCohu, Inc.LTM Jun 2026$97.2M +11.1%-0.1%18.6%
AEHRAehr Test SystemsLTM May 2026$12.63M +20.7%+21.0%24.8%
TRTTrio-Tech InternationalLTM Mar 2026$391K +3.2%+0.8%0.7%
Peer median (excluding AEHR) $109.49M+8.2%+1.4%12.5%

Competitors are the stored peer set for AEHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Revenue50.83M64.96M66.22M58.97M50M
Cost of Revenue27.16M32.22M33.68M35.04M32.35M
Gross Profit23.67M32.75M32.54M23.93M17.65M
Gross Margin46.6%50.4%49.1%40.6%35.3%
Research & Development5.82M7.13M8.72M10.46M12.63M
Selling, General & Admin10.05M12.24M13.75M17.78M19.16M
Operating Expenses15.87M19.37M22.47M28.25M31.8M
Depreciation & Amortization307K450K1.36M3.39M3.53M
EBITDA9.85M15.07M13.82M(903K)(8.21M)
EBITDA Margin19.4%23.2%20.9%-1.5%-16.4%
Operating Income7.8M13.38M10.08M(4.31M)(14.15M)
Operating Margin15.3%20.6%15.2%-7.3%-28.3%
Interest Income13K1.25M2.39M1.4M1.36M
Interest Expense00000
Other Income / Expenses1.74M1.24M2.38M22K2.41M
Income Before Tax9.54M14.62M12.46M(4.29M)(11.74M)
Pre-Tax Margin18.8%22.5%18.8%-7.3%-23.5%
Income Tax Expense91K60K(20.7M)(381K)(4.61M)
Net Income9.45M14.56M33.16M(3.91M)(7.13M)
Net Margin18.6%22.4%50.1%-6.6%-14.3%
EPS (Basic)0.360.521.15(0.13)(0.23)
EPS (Diluted)0.340.501.12(0.13)(0.23)
Weighted Avg Shares26.01M27.79M28.82M29.58M30.67M
Weighted Avg Shares (Diluted)27.77M29.22M29.62M29.58M30.67M

Aehr Test Systems

NASDAQ:AEHR

Intrinsic Alpha fair value

Locked

Current Price

$49.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.